Berberine Improves Glucose Metabolism in Diabetic Rats by Inhibition of Hepatic Gluconeogenesis
2011

Berberine Improves Glucose Metabolism in Diabetic Rats

Sample size: 9 publication 10 minutes Evidence: moderate

Author Information

Author(s): Xia Xuan, Yan Jinhua, Shen Yunfeng, Tang Kuanxiao, Yin Jun, Zhang Yanhua, Yang Dongjie, Liang Hua, Ye Jianping, Weng Jianping

Primary Institution: The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China

Hypothesis

Does berberine reduce blood glucose through mechanisms other than insulin action?

Conclusion

Berberine improves fasting blood glucose by directly inhibiting gluconeogenesis in the liver, independent of insulin action.

Supporting Evidence

  • Berberine decreased fasting blood glucose significantly in diabetic rats.
  • Gluconeogenic genes PEPCK and G6Pase were reduced in the liver by berberine.
  • Hepatic steatosis was reduced by berberine treatment.
  • Berberine inhibited mitochondrial function in hepatocytes.
  • Insulin signaling pathway was not altered in the liver by berberine.

Takeaway

Berberine is a natural compound that helps lower blood sugar levels in diabetic rats by stopping the liver from making too much sugar.

Methodology

Diabetic rats were treated with berberine for five weeks, and various tests were conducted to measure blood glucose and liver function.

Potential Biases

Potential bias in animal model selection and treatment administration.

Limitations

The study was conducted on rats, and results may not directly translate to humans.

Participant Demographics

Male Sprague-Dawley rats, aged 7-8 weeks.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0016556

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication